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Conclusions: Treatment with GTN increased SCB thickness and 
density during CA. NO inhibits osteoclastic bone resorption in 
vitro, and NO-donors have been shown to increase bone density 
elderly women. High BMD has been associated with CA, whilst 
subchondral bone sclerosis is a histological hallmark of CA 
and is suspected by some to be central to its pathogenesis. 
The results of this study suggest that NO may be an important 
mediator of the SCB changes seen in CA, and provides evidence 
that clinical use of NO donor compounds, such as GTN, may 
contribute to disease progression in CA. 
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Introduction: Hyaluronan.(HA) is a glycosaminoglycan (GAG) 
which is present in synovial fluid and the extracellular cartilage 
matrix (ECM). HA is viscoelastic and concentration of HA in CA 
synovial fluid (SF) is lower than normal SF. Original use of intra- 
articular (IA) HA in CA was to increase the viscosity of SF. Clinical 
effects with IA HA prolong the life of HA in the joint. These find- 
ings can not be explained only by the biomechanical properties. 
Aims: To analyze the biological effects of HA on NO and 
PGE2 synthesis, and on chondrocyte apoptosis. To study the 
importance of the molecular weight of HA on these biological 
effects. 
Material and Methods: Cells were isolated from cartilage 
obtained from joint replacement in CA patients. Chondrocytes 
(75 000 cell/well) were cultured for 24h to detect PGE2 or 48 
hours to measure NO, afterwards they were pre-incubated with 
HA and stimulated with IL-1 5 ng/ml. We have used an HA of low 
molecular weight (HALMW): Hyalgan® (500-730 kDa, Bioiberica 
S.A.) and another HA of high molecular weight (HAHMW): 
Synvisc® (6,000 kDa, Biomatrix Inc), at the following concentra- 
tions: 10 10 ~.g/ml; 50 Xg/ml; 100 ~.g/ml; 150 ~.g/ml and 200 
~g/ml. NO was detected by Greiss reaction and PGE2 was quan- 
tified by a commercial EIA (Amersham) in supernatant. Apoptosis 
was induced by an NO donor and the effect of HA on apoptosis 
was quantified by flow cytometry. 
Results: Both HAs studied do not have any effect on basal pro- 
duction of NO or PGE2. However, HALMW at 200 Xg/ml reduces 
by 70% the NO synthesis and by 45% the synthesis of PGE2 
induced by IL-1. HAHMW does not modify the levels of NO or 
PGE2 induced by IL-1. Both HAs at 200 mg/ml decrease the 
apoptosis induced by NO (HALMW by 40% and HAHMW by 3 
6%). 
Conclusion: In this study, the analysis in chondrocyte of two HAs 
has evidenced that different HAs have different effects. Therefore, 
we can state that molecular weight influences some of the 
biological effects that this molecule has on human articular 
chondrocytes. 
Supported by Bioiberica, S. A., Barcelona, Spain and Universidad 
da coruna, Spain. 
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Aim: Elastoviscous hyaluronan solutions reduce articular pain in 
humans and impulse activity of nociceptors ('pain receptors') in 
experimental animals. The aim of this work was to compare the 
effects of commercial viscoelastic substances with different 
molecular weights on the discharges of joint nociceptors evoked 
by movement of the inflamed rat knee joint. 
Methods: Electrical activity of single fibers innervating the knee 
joint was recorded from fine filaments of the median articular 
nerve of anesthetized rats. Knee joint inflammation was produced 
by intraarticular injection of kaolin and carrageenan. Mechanical 
stimulation consisted in controlled rotations of the knee joint 
within and outside its normal working range, for 10 s every 5 mm. 
Solutions of sodium hyaluronan of different molecular weights 
(MW) (<1,000,000 and <2,000,000) and of the high molecular 
weight (v 6,000,000) hyaluronan derivative hylan G-F 20 were 
injected into the joint cavity (0.05 ml). Impulse discharges 
evoked by the movements were compared before and after 
injection. 
Results: Hylan G-F 20 significantly reduced in the course of 1 
hour the number of nerve impulses evoked by movements to 
about 60 % of the control frequency. MW <2,000,000 hyaluronan 
solutions had a slightly faster (around 30 min) and weaker, but still 
significant effect (reduction to 75% of the control impulse fre- 
quency); MW <1,000,000 hyaluronan solutions did not decrease 
significantly the mean impulse frequency of movement-evoked 
discharges in pain nerve fibers. 
Conclusions: It has been proposed that hyaluronan-derived 
elastoviscous ubstances used for the treatment of articular pain 
act as a viscoelastic filter, reducing the transmission of stretch to 
pain nerve terminals in the joint. High molecular weight hylan 
solutions were more effective than lower molecular weight 
hyaluronan solutions in reducing nerve discharges of pain fibers. 
Thus, it is to be expected that high MW hylan solutions Will have 
more pronounced analgesic effects on human joint pain than 
hyaluronan solutions of lower MW. 
Supported by Genzyme Biosurgery, USA and SAF 99-0066-C02- 
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The presence of serum is indispensable for growing many cell 
types culture. Fetal calf serum (FCS) is commonly used for estab- 
lishing monolayers of articular chondrocytes (AC) and is consid- 
ered as the best source of factors promoting cell growth. The 
development of techniques of chondrocytes' grafting on dam- 
aged articular surfaces has stressed in recent years a need for the 
use of human serum (HS) for preparing and cultivating human AC. 
